VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.300
-0.012 (-3.76%)
Dec 5, 2025, 4:00 PM EST - Market closed
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$17,318
Profits / Employee
-$269,171
Market Cap
36.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 2 days ago - VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis - PRNewsWire
- 11 days ago - VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use - PRNewsWire
- 22 days ago - VolitionRx Limited (VNRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update - PRNewsWire
- 26 days ago - VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - PRNewsWire
- 7 weeks ago - Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs - PRNewsWire
- 2 months ago - VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants - PRNewsWire
- 2 months ago - VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants - PRNewsWire